![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
A more recent version of this article appeared on September 1, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 14, 2003
Revised on May 15, 2003
Accepted on May 22, 2003
1 Institute for Biotechnological Research, University of San Martin,
CC30, (1650) San Martin, Argentina
2 Department of
Pathobiology, University of Illinois at Urbana-Chapaign, 2001 S.
Lincoln Ave., Urbana IL 61802-6178, USA
* Corresponding author. E-mail address: aparodi{at}leloir.org.ar.
Lectin (calreticulin, CRT)-N-glycan-mediated quality control of glycoprotein folding is operative in trypanosomatid protozoa but protein-linked monoglucosylated N-glycans are exclusively formed in these microorganisms by UDP-Glc:glycoprotein glucosyltransferase (GT)-dependent glucosylation. The gene coding for this enzyme in the human pathogen Trypanosoma cruzi was identified and sequenced. Even though several of this parasite glycoproteins have been identified as essential components of differentiation and mammalian cell invasion processes, disruption of both GT-encoding alleles did not affect cell growth rate of epimastigote form parasites, and only partially affected differentiation and mammalian cell invasion. The cellular content of one of the already identified T. cruzi glycoprotein virulence factors (cruzipain, a lysosomal proteinase) only showed a partial (5-20%) decrease in GT null mutants in spite of the fact that >90% of all cruzipain molecules interacted with CRT during their folding process in wild-type cells. Although extremely mild cell lysis and immunoprecipitation procedures were used, no CRT-cruzipain interaction was detected in GT null mutants but secretion of the proteinase was nevertheless delayed due to a lengthened interaction with Grp78/BiP probably caused by the detected induction of this chaperone in GT null mutants. This result provides a rationale for the absence of a more drastic consequence of GT absence. It was concluded that T. cruzi endoplasmic reticulum folding machinery presents an exquisite plasticity that allows the parasite to surmount the absence of the glycoprotein-specific folding facilitation mechanism.
This article has been cited by other articles:
|
|
 |
|
  D. C. Turnock and M. A. J. Ferguson Sugar Nucleotide Pools of Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major Eukaryot. Cell, August 1, 2007; 6(8): 1450 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Banerjee, P. Vishwanath, J. Cui, D. J. Kelleher, R. Gilmore, P. W. Robbins, and J. Samuelson The evolution of N-glycan-dependent endoplasmic reticulum quality control factors for glycoprotein folding and degradation PNAS, July 10, 2007; 104(28): 11676 - 11681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Jones, A. Mehlert, M. L. S. Guther, and M. A. J. Ferguson Deletion of the Glucosidase II Gene in Trypanosoma brucei Reveals Novel N-Glycosylation Mechanisms in the Biosynthesis of Variant Surface Glycoprotein J. Biol. Chem., October 28, 2005; 280(43): 35929 - 35942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Ferreira, C. Valck, G. Sanchez, A. Gingras, S. Tzima, M. C. Molina, R. Sim, W. Schwaeble, and A. Ferreira The Classical Activation Pathway of the Human Complement System Is Specifically Inhibited by Calreticulin from Trypanosoma cruzi J. Immunol., March 1, 2004; 172(5): 3042 - 3050. [Abstract] [Full Text] [PDF]
|
|
